Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-24 of 100
» View herald-mail.com items only
    Apr 5, 2013 |Story| Hartford Courant

  1. Pfizer Partners With Nanotechnology Firm

    McClatchy-Tribune News Service
    Pfizer Inc. said Wednesday that a new collaboration with Massachusetts-based BIND Therapeutics could eventually lead to drug work at company laboratories in Groton. New York-based Pfizer confirmed a deal Wednesday that would pay BIND up to $200 million...

    Tags: Health Treatments, Technology, Groton, Nanotechnology, Pharmaceuticals

    2. Mar 29, 2013 |Story| Los Angeles Times

  2. Remove Medicare's straitjacket

    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although raising the age of Medicare eligibility from 65 to 67 appears off the table, at least for now, the budget plan that Rep. Paul D. Ryan (R-Wis.) is proposing would shift a greater share of the program's growing costs to beneficiaries in the years to come.
    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...

    Tags: Drugs and Medicines, Government Health Care, Private Health Care, Food and Drug Administration, Fiscal Cliff

    3. Mar 17, 2013 |Story| Los Angeles Times

  3. Battle over 'biosimilars'

    One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies what amounts to a 12-year monopoly on the substances they developed. Now, supporters of biologics are pushing lawmakers in Sacramento and other state capitals to put new hurdles in the way of knock-off compounds, called "biosimilars."
    One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies...

    Tags: Drugs and Medicines, Jerry Hill, Food and Drug Administration, U.S. Congress, Health and Medical Professionals

    4. Mar 7, 2013 |Story| Baltimore Sun

  4. Government favors big corporations

    We average people vote but we don't get much respect from our government these days nor from some of our representatives. The government gives our taxpayer money and tax breaks to big companies and corporations that don't pay taxes and often don't pay...

    Tags: Goldman Sachs Group, Inc., Voting, Politics, U.S. Postal Service, Mail Order Industry

    5. Mar 7, 2013 |Story| Los Angeles Times

  5. Teams announced for 2013 Amgen Tour of California

    Amgen Tour of California announced that 16 teams will participate in the 2013 race that will run from May 12-19.
    Amgen Tour of California announced that 16 teams will participate in the 2013 race that will run from May 12-19. Returning for its sixth year is Belgium team Omega Pharama-Quick Step Cycling, whose roster includes popular sprinter Tom Boonen, whose...

    Tags: Peter Sagan, Tejay van Garderen, Cycling Trial, Tour de France, 50 Cent

    6. Mar 11, 2013 |Story| Allentown Morning Call

  6. Now in Lehigh Valley, Avantor hopes to grow into billion-dollar business

    Two years ago Avantor Performance Materials was headquartered in the aging New Jersey building it had occupied for half a century, with some of its people working in office trailers and others at a remote site miles away.
    Two years ago Avantor Performance Materials was headquartered in the aging New Jersey building it had occupied for half a century, with some of its people working in office trailers and others at a remote site miles away. Today, relocated to Upper...

    Tags: Global Expansion, Politics, Economy, Business and Finance, Biotechnology, Mergers, Acquisitions and Takeovers

    7. Jan 24, 2013 |Story| Los Angeles Times

  7. Lawmakers look to repeal Medicare provision aiding Amgen drug

    A bipartisan group of U.S. lawmakers is seeking to repeal a Medicare-pricing provision in the recent "fiscal cliff" deal that benefits biotech giant Amgen Inc.
    A bipartisan group of U.S. lawmakers is seeking to repeal a Medicare-pricing provision in the recent "fiscal cliff" deal that benefits biotech giant Amgen Inc. U.S. Rep. Peter Welch (D-Vt.) filed legislation this week to eliminate the exemption for a...

    Tags: Government Health Care, U.S. Congress, Prices, Jim Cooper, Health Insurance Cost

    8. Jan 4, 2013 |Story| Baltimore Sun

  8. Amgen to pay Maryland $856,000 in drug marketing case

    Drug company Amgen Inc. will pay the Maryland Medicaid system $856,474 to settle allegations that it illegally marketed and priced drugs used to treat anemia, rheumatoid arthritis and other diseases. The settlement, announced Friday by Maryland...

    Tags: Rheumatoid Arthritis, Douglas F. Gansler

    9. Dec 18, 2012 |Story| Los Angeles Times

  9. Amgen pleads guilty, to settle misbranding case for $762 million

    Biotech giant Amgen Inc. pleaded guilty to a federal misdemeanor of misbranding its anemia drug Aranesp and has agreed to pay $762 million in fines and penalties. The Thousand Oaks company said it had reached a preliminary settlement of federal criminal...

    Tags: Government Health Care, Prosecution, Food and Drug Administration, Judges, Trials

    10. Jan 5, 2013 |Column| Los Angeles Times

  10. Corporations and execs need penalties that hurt

    If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys.
    If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys. The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of...

    Tags: Phil Angelides , U.S. Department of Justice, Countrywide Financial Corp., Abbott Laboratories, Lawyers

    11. Sep 15, 2012 |Story| Los Angeles Times

  11. 5 Questions: Patrick Dempsey

    Patrick Dempsey, the actor also known as "McDreamy," just committed to two more seasons on the hospital drama "Grey's Anatomy." But it's when the camera isn't rolling that Dempsey, 46, is really busy. He's riding bikes and parenting three children with his wife, Jillian, raising money for a cancer charity that he helped found to honor his mother, and racing cars. (In a case of art imitating life, Dempsey expects to start shooting the film adaptation of the bestselling book "The Art of Racing in the Rain" soon. He'll play race-car driver Denny Swift.)
    Patrick Dempsey, the actor also known as "McDreamy," just committed to two more seasons on the hospital drama "Grey's Anatomy." But it's when the camera isn't rolling that Dempsey, 46, is really busy. He's riding bikes and parenting three children with...

    Tags: Acupuncture, Cancer, Patrick Dempsey, Physiology, Physical Fitness and Exercise

    12. May 21, 2012 |Story| KTLA-LTV

  12. Super Sports Sunday is Boom for Business, Bust for Drivers

    LOS ANGELES (KTLA) -- An action-packed sports schedule at and around Staples Center in Downtown L.A. caused driving and parking challenges on Sunday.
    KTLA News
    LOS ANGELES (KTLA) -- An action-packed sports schedule at and around Staples Center in Downtown L.A. caused driving and parking challenges on Sunday. The Amgen bike race, which began in Beverly Hills, finished in the area outside Staples Center around...

    Tags: Phoenix Coyotes, San Antonio Spurs, Western Conference (NHL), Staples Center, NBA Playoffs

< Previous • 1  2  3 4 5 6 7 8 9 • Next >
Original site for Amgen Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Amgen Inc. Photos
Some firms seek to make "biosimilar" drugs that would p...
(April 25, 2013)
Bill would regulate &#8216;biosimilar&#8217; drugs
, Rathmann was the Thousand Oaks firm's first chief exe...
(April 25, 2012)
George B. Rathmann
Davies, 50, brings to Hospira more than 20 years of str...
(January 31, 2012)
Richard Davies, chief commercial officer, Hospira
 » All 4 Amgen Inc. photos